The Roles of Tripartite Motif Proteins in Urological Cancers: A Systematic Review
Cancers · 16.07.2025 · 17 (14) · 2367
DOI: 10.3390/cancers17142367 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.07.2025. Verfasst von Yuta Yamada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo 113-8655, Japan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yamaguchi Endocrine Research Association.
Abstract (Originalsprache)
We aimed to investigate the roles of tripartite motif (TRIM) proteins in urological cancers.
Methods
A systematic review was conducted to investigate the oncological role of tripartite motif proteins in urological cancers.
Results
A total of 84 articles were identified for the final analysis (26 articles on kidney cancers, 19 on bladder cancers, 37 on prostate cancers, and 1 on testicular cancers). In total, 27 TRIM family proteins were involved in kidney cancer, of which 9 were associated with tumor-promoting findings (TRIM24, TRIM27, TRIM37, TRIM44, TRIM46, TRIM47, TRIM59, TRIM63, and TRIM65) and of which 9 TRIM proteins were tumor-suppressive (TRIM2, TRIM7, TRIM8, TRIM13, TRIM21, TRIM26, TRIM28, TRIM33, and TRIM58). Fourteen TRIM family proteins were associated with bladder cancer (tumor-promoting: TRIM9, TRIM25, TRIM26, TRIM28, TRIM29, TRIM59, TRIM65, and TRIM66; tumor-suppressive: TRIM19 and TRIM38). Ten TRIM family proteins were associated with prostate cancer (tumor-promoting: TRIM11, TRIM24, TRIM28, TRIM33, TRIM44, TRIM59, TRIM63, TRIM66, and TRIM68; tumor-suppressive: TRIM32 and TRIM36). Twenty-eight TRIM family proteins were identified to be associated with prostate cancer (tumor-promoting: TRIM11, TRIM24, TRIM28, TRIM33, TRIM44, TRIM59, TRIM63, TRIM66, and TRIM68; tumor-suppressive: TRIM32 and TRIM36). TRIM proteins regulate urological cancers by ubiquitination or modulation of oncologic pathways.
Conclusions
This review identifies TRIM proteins that are involved in urological cancers. Some of these proteins have the potential to be the therapeutic target.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo 113-8655, Japan.
- Department of Urology, The Jikei University Daisan Hospital, Komae-Shi 201-8601, Tokyo, Japan.
- Toneri Urology Clinic, Adachi-Ku, Tokyo 121-0831, Japan.
- Department of Urology, Jichi Medical University, Shimotsuke-Shi 329-0498, Tochigi, Japan.
- Systems Aging Science and Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology (TMIG), Itabashi-Ku, Tokyo 173-0015, Japan.
ORCID-Profile: Fumihiko Urabe, Satoshi Inoue
Förderung
- Yamaguchi Endocrine Research Association
Zitieren
APA
Yamada, Y., Kimura, N., Maki, K., Hakozaki, Y., Urabe, F., Kimura, S., Fujimura, T., Inoue, S., & Kume, H. (2025). The Roles of Tripartite Motif Proteins in Urological Cancers: A Systematic Review. Cancers, 17(14), 2367. https://doi.org/10.3390/cancers17142367
Vancouver
Yamada Y, Kimura N, Maki K, Hakozaki Y, Urabe F, Kimura S, et al. The Roles of Tripartite Motif Proteins in Urological Cancers: A Systematic Review. Cancers. 2025;17(14):2367. doi:10.3390/cancers17142367
BibTeX
@article{Yamada2025,
author = {Yamada, Yuta and Kimura, Naoki and Maki, Kazuki and Hakozaki, Yuji and Urabe, Fumihiko and Kimura, Shoji and Fujimura, Tetsuya and Inoue, Satoshi and Kume, Haruki},
title = {The Roles of Tripartite Motif Proteins in Urological Cancers: A Systematic Review},
journal = {Cancers},
year = {2025},
volume = {17},
number = {14},
pages = {2367},
doi = {10.3390/cancers17142367}
}
EUVIMED